Back
Compass Pathways PLC Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison
Sell
25
CMPS
Compass Pathways PLC
Last Price:
5.02
Seasonality Move:
19.6%
Sell
4
ADAP
Adaptimmune Therapeutics PLC
Last Price:
0.59
Seasonality Move:
50.57%
Sell
25
Compass Pathways PLC (CMPS)
is a Sell
Is Compass Pathways PLC a Buy, Sell or Hold?
- The current Compass Pathways PLC [CMPS] share price is $5.04. The Score for CMPS is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- CMPS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
4
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?
- The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.59. The Score for ADAP is 4, which is 92% below its historic median score of 50, and infers higher risk than normal.
- ADAP is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
CMPS Stock Price Chart
What is Compass Pathways PLC's stock price today?
-
The Compass Pathways PLC share price today is $5.04
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CMPS is experiencing selling pressure, which indicates risk of future bearish movement.
ADAP Stock Price Chart
What is Adaptimmune Therapeutics PLC's stock price today?
-
The Adaptimmune Therapeutics PLC share price today is $0.59
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing slight selling pressure.
CMPS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.36 | Sell |
| Relative Strength Index (14 RSI): | 39.5 | Sell |
| Chaikin Money Flow: | -3128395 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.94 - 6.32) | Sell |
| Bollinger Bands (100): | (5.77 - 7.39) | Sell |
ADAP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 26.27 | Sell |
| Chaikin Money Flow: | -2051103 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.7 - 0.86) | Sell |
| Bollinger Bands (100): | (0.83 - 1.21) | Sell |
CMPS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.1 | Sell |
| 20-day SMA: | 5.51 | Sell |
| 50-day SMA: | 6.14 | Sell |
| 200-day SMA: | 7.77 | Sell |
| 8-day EMA: | 5.09 | Sell |
| 20-day EMA: | 5.4 | Sell |
| 50-day EMA: | 5.97 | Sell |
| 200-day EMA: | 7.18 | Sell |
ADAP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.75 | Sell |
| 20-day SMA: | 0.76 | Sell |
| 50-day SMA: | 0.88 | Sell |
| 200-day SMA: | 1.13 | Sell |
| 8-day EMA: | 0.71 | Sell |
| 20-day EMA: | 0.77 | Sell |
| 50-day EMA: | 0.87 | Sell |
| 200-day EMA: | 1.01 | Sell |
Compass Pathways PLC Earnings Growth & CMPS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.10 per share, and an increase next year of $0.28 per share.
Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.33 per share, and a decrease next year of $0.38 per share.
Compass Pathways PLC Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Adaptimmune Therapeutics PLC Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||